DIVERSION SERVICE Report 2024–2025

We’re proud to share our Druglink Diversion Service Report 2024–2025. This year’s report highlights continued growth and development, including increased referrals, high participant satisfaction, more neurodiversity-inclusive training, new specialist drug courses, and the launch of women-only provision. Read the full report to see the real impact, real change, and real stories behind the service.